Registry of Lobbyists

Registration - In-house Corporation

PURDUE PHARMA / David Pidduck, President & CEO

Registration Information

In-house Corporation name: PURDUE PHARMA
Responsible Officer Name: David Pidduck, President & CEO 
Responsible Officer Change History
Initial registration start date: 2005-08-17
Registration status: Inactive
Registration Number: 934061-5031

Associated Communications

Total Number of Communication Reports: 57

Monthly communication reports in the last 6 months: 0

Version 1 of 23 (2005-08-17 to 2006-02-24)

Version 1 of 23 (2005-08-17 to 2006-02-24) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: PURDUE PHARMA
575 Granite Court
Pickering, ON  L1W 3W8
Canada
Telephone number: 905-420-4976
Fax number: 905-420-4193  
Responsible officer name and position during the period of this registration: John Stewart, Executive Vice President and GM  
Description of activities: Purdue Pharma is engaged in the research, development, production and distribution of both prescription and over-the-counter medicines and hospital products. The company is particularly active in the area of drug delivery technologies, and markets products for the treatment of pain, respiratory disease, gastrointestinal disorders and infection control.
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Randy Steffan
Position title: Director, Corporate Affairs and Communications
Public offices held: No
 
Name: John Stewart
Position title: Executive Vice President and General Manager
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Royal Canadian Mounted Police (RCMP)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, International Trade
 
Subject Matter: Retrospective: Communication with the Patented Medicine Prices Review Board (PMPRB) regarding proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
Subject Matter: Prospective: Health Canada: ongoing communications regarding risk management programs for controlled prescription drugs and Canada's Drug Strategy.PMPRB: review of pricing submissions for pharmaceutical products.
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation Amendments to Patented Medicine (Notice of Compliance) Regulations and review of pricing submissions for prescription drugs by the Patented Medicine Prices Review Board (PMPRB).
Policy or Program Any changes to the Controlled Substances Act (CDSA) and Narcotic Control Regulations (NCR), as well as policies associated with the Drug Strategy and Controlled Substances Program of Health Canada which impact upon the marketing, sales and distribution of prescription drug products.




Date Modified: